Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
Crizotinib is a tyrosine kinase inhibitor approved for the treatment of non-small-cell lung cancer, but it is inefficient on brain metastases. Crizotinib is a substrate of the P-glycoprotein, and non-invasive nuclear imaging can be used to assess the brain penetration of crizotinib. Positron emissio...
Saved in:
Main Authors: | Malvika Sardana (Author), Louise Breuil (Author), Sébastien Goutal (Author), Maud Goislard (Author), Mikhail Kondrashov (Author), Etienne Marchal (Author), Florent L. Besson (Author), Christophe Dugave (Author), Gail Wrigley (Author), Anna C. Jonson (Author), Bertrand Kuhnast (Author), Magnus Schou (Author), Nicolas Tournier (Author), Charles S. Elmore (Author), Fabien Caillé (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
by: Marion Tisseraud, et al.
Published: (2022) -
Optimized method for fluorine-18 radiolabeling of Affibody molecules using RESCA
by: Francesco Lechi, et al.
Published: (2024) -
Comparison of the Blood-Brain Barrier Transport and Vulnerability to P-Glycoprotein-Mediated Drug-Drug Interaction of Domperidone versus Metoclopramide Assessed Using In Vitro Assay and PET Imaging
by: Louise Breuil, et al.
Published: (2022) -
Development of a fluorine-18 radiolabelled fluorescent chalcone: evaluated for detecting glycogen
by: Louis Allott, et al.
Published: (2020) -
Synthesis, Fluorine-18 Radiolabeling, and In Vivo PET Imaging of a Hydrophilic Fluorosulfotetrazine
by: Jason Beaufrez, et al.
Published: (2023)